BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16527609)

  • 21. BigH3 protein expression as a marker for breast cancer.
    Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
    Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.
    Worsham MJ; Pals G; Schouten JP; Miller F; Tiwari N; van Spaendonk R; Wolman SR
    Breast Cancer Res Treat; 2006 Mar; 96(2):177-86. PubMed ID: 16319984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line.
    Guillaud-Bataille M; Brison O; Danglot G; Lavialle C; Raynal B; Lazar V; Dessen P; Bernheim A
    Cytogenet Genome Res; 2009; 124(1):1-11. PubMed ID: 19372663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
    Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
    Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-myc amplifications in primary breast carcinomas and their local recurrences.
    Aulmann S; Adler N; Rom J; Helmchen B; Schirmacher P; Sinn HP
    J Clin Pathol; 2006 Apr; 59(4):424-8. PubMed ID: 16497871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of chromosomal instability in paired breast surgery and ductal lavage specimens by interphase fluorescence in situ hybridization.
    King BL; Tsai SC; Gryga ME; D'Aquila TG; Seelig SA; Morrison LE; Jacobson KK; Legator MS; Ward DC; Rimm DL; Phillips RF
    Clin Cancer Res; 2003 Apr; 9(4):1509-16. PubMed ID: 12684427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
    Yao J; Weremowicz S; Feng B; Gentleman RC; Marks JR; Gelman R; Brennan C; Polyak K
    Cancer Res; 2006 Apr; 66(8):4065-78. PubMed ID: 16618726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
    Bouchalová K; Trojanec R; Kolár Z; Cwiertka K; Cernáková I; Mihál V; Hajdúch M
    Neoplasma; 2006; 53(5):393-401. PubMed ID: 17013533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.
    Shen D; Nooraie F; Elshimali Y; Lonsberry V; He J; Bose S; Chia D; Seligson D; Chang HR; Goodglick L
    Hum Pathol; 2006 Dec; 37(12):1583-91. PubMed ID: 16949910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
    Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
    Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative implication of C-MYC as an amplification target in esophageal cancer.
    Huang XP; Rong TH; Wang JY; Tang YQ; Li BJ; Xu DR; Zhao MQ; Zhang LJ; Fang Y; Su XD; Liang QW
    Cancer Genet Cytogenet; 2006 Feb; 165(1):20-4. PubMed ID: 16490593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast.
    Mariani-Costantini R; Escot C; Theillet C; Gentile A; Merlo G; Lidereau R; Callahan R
    Cancer Res; 1988 Jan; 48(1):199-205. PubMed ID: 2825967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
    Rodríguez-Pinilla SM; Rodríguez-Gil Y; Moreno-Bueno G; Sarrió D; Martín-Guijarro Mdel C; Hernandez L; Palacios J
    Am J Surg Pathol; 2007 Apr; 31(4):501-8. PubMed ID: 17414096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
    Bubendorf L; Kononen J; Koivisto P; Schraml P; Moch H; Gasser TC; Willi N; Mihatsch MJ; Sauter G; Kallioniemi OP
    Cancer Res; 1999 Feb; 59(4):803-6. PubMed ID: 10029066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer.
    Adduci KM; Annis CE; DeVries S; Chew KL; Boutin J; Magrane G; Ljung BM; Waldman FM; Esserman LJ
    Cancer; 2007 Jun; 111(3):185-91. PubMed ID: 17474121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
    Park K; Han S; Kim HJ; Kim J; Shin E
    Histopathology; 2006 May; 48(6):702-7. PubMed ID: 16681686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of high copy number of HER2 associated with polysomy 17 on HER2 protein expression in invasive breast carcinoma.
    Shah SS; Wang Y; Tull J; Zhang S
    Diagn Mol Pathol; 2009 Mar; 18(1):30-3. PubMed ID: 19214111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.